Last reviewed · How we verify

NCT03652519: TRAINUVIMAB

High-intensity Training and Its Effects on Neuroplasticity

Completed NA Last updated 13 November 2019
What this trial tests

NA trial testing Exercise Training in Multiple Sclerosis in 72 participants. Completed in 11 November 2019.

Timeline
21 November 2018
Primary endpoint
11 November 2019
11 November 2019

Quick facts

Lead sponsorKlinik Valens
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment72
Start date21 November 2018
Primary completion11 November 2019
Estimated completion11 November 2019
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Klinik Valens

Who can join

21 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Regular physical activity is known to reduce the risk for some neurodegenerative disorders and their symptoms. Several studies have shown positive effects of therapeutic exercise interventions on motor- and cognitive function as well as psychosocial benefits in persons with multiple sclerosis (MS). To improve exercise recommendations, it is necessary to learn more about the underlying biological mechanisms. A reduction of inflammatory stress through physical exercise has been suspected as one key mechanism, mediating the positive effects of exercise in the context of MS (being a "classical" neuro-inflammatory disease). This randomized controlled trial aims to investigate the influence of two different rehabilitative endurance exercise programs (3x/week moderate vs. vigorous endurance exercise) on (1) (anti-)inflammatory immune signalling and (2) various aspects of participation.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis.
    Joisten N, Rademacher A, Warnke C, Proschinger S, et al · · 2021 · cited 54× · PMID 33782190 · DOI 10.1212/nxi.0000000000000982
  2. Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.
    Joisten N, Rademacher A, Bloch W, Schenk A, et al · · 2019 · cited 16× · PMID 30849952 · DOI 10.1186/s12883-019-1267-9
  3. Cognitive Impairment Impacts Exercise Effects on Cognition in Multiple Sclerosis.
    Rademacher A, Joisten N, Proschinger S, Bloch W, et al · · 2020 · cited 6× · PMID 33633658 · DOI 10.3389/fneur.2020.619500

Verify or expand the search:

Other trials of Exercise Training

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Klinik Valens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03652519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing